mammary epithelial cell basal medium Search Results


human mammary epithelial adenocarcinoma cells  (ATCC)
99
ATCC human mammary epithelial adenocarcinoma cells
Human Mammary Epithelial Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mammary epithelial adenocarcinoma cells/product/ATCC
Average 99 stars, based on 1 article reviews
human mammary epithelial adenocarcinoma cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
benign breast cancer cell line mcf 10a  (PromoCell)
94
PromoCell benign breast cancer cell line mcf 10a
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Benign Breast Cancer Cell Line Mcf 10a, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/benign breast cancer cell line mcf 10a/product/PromoCell
Average 94 stars, based on 1 article reviews
benign breast cancer cell line mcf 10a - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
serum-free mammary epithelial cell basal medium pcs-600-030  (Cedarlane)
90
Cedarlane serum-free mammary epithelial cell basal medium pcs-600-030
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Serum Free Mammary Epithelial Cell Basal Medium Pcs 600 030, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum-free mammary epithelial cell basal medium pcs-600-030/product/Cedarlane
Average 90 stars, based on 1 article reviews
serum-free mammary epithelial cell basal medium pcs-600-030 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mammary epithelial cell basal medium (mebm)  (Beijing Solarbio Science)
90
Beijing Solarbio Science mammary epithelial cell basal medium (mebm)
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Mammary Epithelial Cell Basal Medium (Mebm), supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mammary epithelial cell basal medium (mebm)/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
mammary epithelial cell basal medium (mebm) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mammary epithelial cell basal medium  (Fisher Scientific)
90
Fisher Scientific mammary epithelial cell basal medium
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Mammary Epithelial Cell Basal Medium, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mammary epithelial cell basal medium/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
mammary epithelial cell basal medium - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
megmtm mammary epithelial cell growth medium bulletkittm (mebmtm basal medium and megmtm singlequotstm supplements)  (Lonza)
90
Lonza megmtm mammary epithelial cell growth medium bulletkittm (mebmtm basal medium and megmtm singlequotstm supplements)
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Megmtm Mammary Epithelial Cell Growth Medium Bulletkittm (Mebmtm Basal Medium And Megmtm Singlequotstm Supplements), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/megmtm mammary epithelial cell growth medium bulletkittm (mebmtm basal medium and megmtm singlequotstm supplements)/product/Lonza
Average 90 stars, based on 1 article reviews
megmtm mammary epithelial cell growth medium bulletkittm (mebmtm basal medium and megmtm singlequotstm supplements) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mebmtm mammary epithelial basal medium and supplementation (megmtm mammary epithelial cell growth medium kit)  (Lonza)
90
Lonza mebmtm mammary epithelial basal medium and supplementation (megmtm mammary epithelial cell growth medium kit)
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Mebmtm Mammary Epithelial Basal Medium And Supplementation (Megmtm Mammary Epithelial Cell Growth Medium Kit), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mebmtm mammary epithelial basal medium and supplementation (megmtm mammary epithelial cell growth medium kit)/product/Lonza
Average 90 stars, based on 1 article reviews
mebmtm mammary epithelial basal medium and supplementation (megmtm mammary epithelial cell growth medium kit) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mebmmtm mammary epithelial cell growth basal medium, phenol red free  (Lonza)
90
Lonza mebmmtm mammary epithelial cell growth basal medium, phenol red free
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Mebmmtm Mammary Epithelial Cell Growth Basal Medium, Phenol Red Free, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mebmmtm mammary epithelial cell growth basal medium, phenol red free/product/Lonza
Average 90 stars, based on 1 article reviews
mebmmtm mammary epithelial cell growth basal medium, phenol red free - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mammary epithelial cell basal medium  (PromoCell)
94
PromoCell mammary epithelial cell basal medium
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Mammary Epithelial Cell Basal Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mammary epithelial cell basal medium/product/PromoCell
Average 94 stars, based on 1 article reviews
mammary epithelial cell basal medium - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
normal human mammary epithelial cell basal medium  (Lonza)
90
Lonza normal human mammary epithelial cell basal medium
SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of <t>MCF-10A</t> ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.
Normal Human Mammary Epithelial Cell Basal Medium, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal human mammary epithelial cell basal medium/product/Lonza
Average 90 stars, based on 1 article reviews
normal human mammary epithelial cell basal medium - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of MCF-10A ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.

Journal: Scientific Reports

Article Title: Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines

doi: 10.1038/s41598-020-80850-9

Figure Lengend Snippet: SSRI treatment or 5-HT exposure marginally impact cell proliferation of breast cancer cell lines. Bar graphs depict relative proliferation assessed by Fluoroskan of MCF-10A ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA- MSC-hyb3 ( e ) cells in response to treatment with 10 nM, 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods normalized to DMSO-treated control cells (Ctrl; white). Data are depicted as mean ± SEM and summarize n = 9–10 (Ctrl) and at least n = 3 (SSRI/5-HT) experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.

Article Snippet: The benign breast cancer cell line MCF-10A was grown in phenol red-free Mammary Epithelial Cell Basal Medium (MECBM) with appropriate supplement mix (PromoCell, Heidelberg, Germany).

Techniques:

Effect of low-dose, long-term SSRI treatment or 5-HT exposure on breast cancer cell lines measured by MTT assay. Bar graphs depict relative absorbance of MTT assay of MCF-10A ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA-MSC-hyb3 ( e ) cells in response to treatment with 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods (96 h to 144 h) compared to DMSO-treated control cells (Ctrl; white) and cells receiving carboplatin (CP; 1000 nM; black). Data are depicted as mean ± SEM and summarize n = 3 experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.

Journal: Scientific Reports

Article Title: Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines

doi: 10.1038/s41598-020-80850-9

Figure Lengend Snippet: Effect of low-dose, long-term SSRI treatment or 5-HT exposure on breast cancer cell lines measured by MTT assay. Bar graphs depict relative absorbance of MTT assay of MCF-10A ( a ), MCF-7 ( b ), MDA-MB-231 ( c ), MDA-MSC-hyb1 ( d ) and MDA-MSC-hyb3 ( e ) cells in response to treatment with 100 nM or 1000 nM fluoxetine (Fluo; yellow), sertraline (Sert; red), citalopram (Cita; blue) or 5-HT (grey) for indicated time periods (96 h to 144 h) compared to DMSO-treated control cells (Ctrl; white) and cells receiving carboplatin (CP; 1000 nM; black). Data are depicted as mean ± SEM and summarize n = 3 experiments. P -values were determined by two-way ANOVA followed by Dunnett’s multiple comparison test; *** P < 0.001; ** P < 0.01; * P < 0.05 versus corresponding Ctrl.

Article Snippet: The benign breast cancer cell line MCF-10A was grown in phenol red-free Mammary Epithelial Cell Basal Medium (MECBM) with appropriate supplement mix (PromoCell, Heidelberg, Germany).

Techniques: MTT Assay

Fluoxetine and sertraline marginally increase glucose uptake in SK-OV-3 cells. Bar graphs depict relative cellular glucose uptake assessed by 18F-FDG incorporation of MCF-10A ( a ), MCF-7 ( b ) and MDA-MB-231 ( c ) breast cancer as well as SK-OV-3 ( d ) NIH:OVCAR-3 ( e ) and SK-MSC-hyb1 ( f ) ovarian cancer cells in response to stimulation with 1 µM fluoxetine (Fluo), sertraline (Sert), citalopram (Cita), or 5-HT relative to DMSO-treated control cells (Ctrl) for 72 h. Data, derived from n = 3 (b and e), n = 4 (a and c) or n = 5 (d and e) independent cell passages performed in duplicates, are depicted as means ± SEM. P -values were computed by one-way ANOVA followed by Dunnett’s multiple comparison test; ** P < 0.01.

Journal: Scientific Reports

Article Title: Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines

doi: 10.1038/s41598-020-80850-9

Figure Lengend Snippet: Fluoxetine and sertraline marginally increase glucose uptake in SK-OV-3 cells. Bar graphs depict relative cellular glucose uptake assessed by 18F-FDG incorporation of MCF-10A ( a ), MCF-7 ( b ) and MDA-MB-231 ( c ) breast cancer as well as SK-OV-3 ( d ) NIH:OVCAR-3 ( e ) and SK-MSC-hyb1 ( f ) ovarian cancer cells in response to stimulation with 1 µM fluoxetine (Fluo), sertraline (Sert), citalopram (Cita), or 5-HT relative to DMSO-treated control cells (Ctrl) for 72 h. Data, derived from n = 3 (b and e), n = 4 (a and c) or n = 5 (d and e) independent cell passages performed in duplicates, are depicted as means ± SEM. P -values were computed by one-way ANOVA followed by Dunnett’s multiple comparison test; ** P < 0.01.

Article Snippet: The benign breast cancer cell line MCF-10A was grown in phenol red-free Mammary Epithelial Cell Basal Medium (MECBM) with appropriate supplement mix (PromoCell, Heidelberg, Germany).

Techniques: Derivative Assay